We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+13.62%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87M
AUM Growth
-$6.82M
(-7.3%)
Cap. Flow
+$46M
Cap. Flow
% of AUM
52.86%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
838
New
190
Increased
180
Reduced
205
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$49.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$12.1M |
| 3 |
SENT
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
|
+$1.42M |
| 4 |
Zscaler
ZS
|
+$1.05M |
| 5 |
Nike
NKE
|
+$947K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.87M |
| 2 |
Snap
SNAP
|
+$1.28M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.16M |
| 4 |
NXP Semiconductors
NXPI
|
+$1.16M |
| 5 |
Tractor Supply
TSCO
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.1% |
| 2 | Consumer Discretionary | 19.26% |
| 3 | Financials | 4.57% |
| 4 | Healthcare | 4.2% |
| 5 | Communication Services | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Boyd Gaming
BYD
$6.05B
| $2K | ﹤0.01% |
40
-101
| -72% | -$5.49K |
|
552
CarGurus
CARG
$3.38B
| $2K | ﹤0.01% |
113
-25,598
| -100% | -$742K |
|
553
Cardlytics
CDLX
$25.1M
| $2K | ﹤0.01% |
+3
| New | +$3.96K |
|
554
Chegg
CHGG
$89.3M
| $2K | ﹤0.01% |
44
+35
| +389% | +$3.33K |
|
555
Chewy
CHWY
$9.2B
| $2K | ﹤0.01% |
27
| – | – |
|
556
Corteva
CTVA
$50.6B
| $2K | ﹤0.01% |
64
| – | – |
|
557
Camping World
CWH
$675M
| $2K | ﹤0.01% |
80
| – | – |
|
558
Deere & Co
DE
$165B
| $2K | ﹤0.01% |
+8
| New | +$2.63K |
|
559
Digital Realty Trust
DLR
$73.1B
| $2K | ﹤0.01% |
16
| – | – |
|
560
EXL Service
EXLS
$5.36B
| $2K | ﹤0.01% |
135
| – | – |
|
561
Fortune Brands Innovations
FBIN
$5.78B
| $2K | ﹤0.01% |
+36
| New | +$2.73K |
|
562
F5
FFIV
$23.6B
| $2K | ﹤0.01% |
16
-2,721
| -99% | -$536K |
|
|
FITB
563
Fifth Third Bancorp
FITB
$52.5B
| $2K | ﹤0.01% |
59
| – | – |
|
564
Fulgent Genetics
FLGT
$513M
| $2K | ﹤0.01% |
+31
| New | +$3.2K |
|
565
Howard Hughes
HHH
$4.04B
| $2K | ﹤0.01% |
33
-81
| -71% | -$7.13K |
|
|
HIMX
566
Himax Technologies
HIMX
$2.56B
| $2K | ﹤0.01% |
157
-597
| -79% | -$6.98K |
|
567
Jazz Pharmaceuticals
JAZZ
$16B
| $2K | ﹤0.01% |
15
| – | – |
|
568
Masco
MAS
$14.7B
| $2K | ﹤0.01% |
50
-101
| -67% | -$5.64K |
|
569
Medtronic
MDT
$116B
| $2K | ﹤0.01% |
19
| – | – |
|
570
Medifast
MED
$128M
| $2K | ﹤0.01% |
13
| – | – |
|
571
Magnite
MGNI
$3.53B
| $2K | ﹤0.01% |
+72
| New | +$3.12K |
|
572
Ocular Therapeutix
OCUL
$2.22B
| $2K | ﹤0.01% |
127
+45
| +55% | +$867 |
|
573
Organogenesis Holdings
ORGO
$226M
| $2K | ﹤0.01% |
+163
| New | +$2.21K |
|
574
PAR Technology
PAR
$770M
| $2K | ﹤0.01% |
43
+19
| +79% | +$1.41K |
|
575
Penumbra
PEN
$12.9B
| $2K | ﹤0.01% |
+11
| New | +$2.84K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Alpha DNA Investment Management held 838 positions worth $87M, down 7.3% from $93.9M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Alpha DNA Investment Management deployed $46M of net new capital in Q1 2021, opening 190 new positions and adding to 180 existing holdings. Its largest new stake was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $1.87M trimmed.
- Alpha DNA Investment Management's largest Q1 2021 buy was AdvisorShares Alpha DNA Equity Sentiment ETF: 54,604 shares worth $1.41M.
- Alpha DNA Investment Management added most to iShares Russell 2000 ETF in Q1 2021, an estimated $49.7M increase.
- Alpha DNA Investment Management's biggest Q1 2021 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $1.87M.
- Alpha DNA Investment Management fully exited BlackLine in Q1 2021, selling an estimated $475K.
- Alpha DNA Investment Management's ten largest holdings make up 19% of its $87M portfolio in Q1 2021.
- Alpha DNA Investment Management opened 190 new positions and closed 92 in Q1 2021.
- Alpha DNA Investment Management's portfolio value fell 7.3% quarter-over-quarter to $87M.
Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.